Latest Views & News

SkinBioTherapeutics – announces AxisBiotix-Ps launch date, high margin profit potential moving closer - we are 289% ahead but much more to come

By Tom Winnifrith and Steve Moore | Friday 1 October 2021


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


As things stand at 69p, we are 289% ahead on this share tip but there is much more to come. SkinBioTherapeutics (SBTX) has announced its probiotic food supplement to help alleviate the symptoms of psoriasis, AxisBiotix-Ps, is to launch on 29th October, following highly positive results from its consumer study in May and key commercialisation activities since.

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Tuesday »

SNX

Synectics – a recovery Buy?

 

GetAFix

Malcolm Stacey is Moving House

Monday »

WG

Wood Group - a Buy (again)?

 

Bear

Video: Bubbles always implode